Home Research & Development Our Products Contact Us Terms of Use Sitemap
       
     
Nostrum Pharmaceuticals
Nostrum Technologies
Symmetrix
  Pharmaceutical composition comprising cyclosporine in association with a carrier in a
self-emulsifying drug delivery system, US6,057,289, May 2, 2000.
Sustained release tablet containing hydrocolloid and cellulose ether,  US6,416,786. July 9, 2002.
Self-emulsifying compositions for drugs poorly soluble in water, US6,436,430, August 20, 2002.
Controlled release oral dosage for suitable for oral administration, US 6,437,000,  August 20, 2002.
Controlled release pellet formulation, US 6,475,493, November 5, 2002.
Controlled release pellet formulation, US6,635,680, October 21, 2003.
Micro emulsion concentrate composition of cyclosporine, US6,638,522, October 28, 2003
Coating for a sustained release pharmaceutical composition, US6,946,146, September 20, 2005.
Control release formulation containing a hydrophobic material as the sustained release agent, US7,052,706, May 30, 2006.
Process for Preparing Sustained Release Tablets US7,179,486, February 20, 2007.

 

 

 

 

 
     
   
Best Viewed at 1024x768, IE 7.0
 
   
© Nostrum Pharmaceuticals LLC. 2008